[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 19, Issue 5 (Iranian South Medical Journal 2016) ::
Iran South Med J 2016, 19(5): 773-786 Back to browse issues page
Using Hydroxyapatite-Gelatin Scaffold Seeded with Bone Marrow Stromal Cells as a Bone Graft in Animal Model
Mahsoumeh Behruzi1, Hatef Ghasemi Hamidabadi1, Mazaher Gholipour Malekabadi2, Noorollah Rezaei1, Maryam Nazm Bojnordi1, Majid Malekzadeh Shafaroudi 3
1- Immunogenetic Research Center (IRC), Department of Anatomy & Cell Biology, .School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
2- Biotechnology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Immunogenetic Research Center (IRC), Department of Anatomy & Cell Biology, .School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran , malek1344@gmail.com
Abstract:   (4469 Views)

Background: Nowadays, composite scaffolds with some desired characteristics have a numerous applications in hard tissue engineering. In present study, the role of composite hydroxyapatite - gelatin was examined in both alone and coated by Bone Marrow Stromal Stem Cells (BMSCs) conditions in the process of healing bone defects, reduction of time repair and the immune response of body by laboratory studies (in vitro) and in vivo on the skull of adult rats as well.

Materials and Methods: In present study, nano-hydroxyapatite powder and gelatin were used to provide nano-hydroxyapatite-gelatin scaffold, BMSCs were isolated by Flushing method. Fifteen adult male Wistar rats weighing 250-200 g were used. Studing groups included bone defect with hydroxyapatite-gelatin scaffold, bone defect with hydroxyapatite-gelatin with BMSCs and bone defects without scaffolding as a controlwhich were examined after a week and a month after surgery. MTT assay was used in order to evaluation of biocompatibility of scaffolds. To confirm the healing progress trend and the presence of inflammatory cells we used hematoxylin-eosin and we used Masson's trichrome staining in order to study of synthesis of collagen fibers.

Results: The results of MTT showed that the scaffold has no toxic effects on stromal cells. The first signs of ossification in hydroxyapatite-gelatin with BMSCs cells group, appeared in the first week. However, in the fourth week, ossification was completed and the scaffold remaining was found as embedded islands in the spongy bone tissue. The greatest number of lymphocytes was observed in the experimental group after one week of planting scaffold.

Conclusion: it seems that Hydroxyapatite-gelatin scaffold coated with BMSCs cells has a potential role in the healing process of bone and it can be suitable as a therapeutic strategy to repair extensive bone lesions.

Keywords: Transplantation, Scaffold, Rat, Bone marrow mesenchymal stem cell, Tissue engineering
Full-Text [PDF 583 kb]   (1987 Downloads)    
Type of Study: Original | Subject: Musculoskeletal System
Received: 2016/11/17 | Accepted: 2016/11/17 | Published: 2016/11/17
1. Wegman F, Poldervaart MT, van der Helm YJ, et al. Combination of bone morphogenetic protein-2 plasmid DNA with chemokine CXCL12 creates an additive effect on bone formation onset and volume. Eur Cell Mater 2015; 30: 1-11. [PubMed] [Google Scholar]
2. Mobini S, Solati-Hashjin M, Hesaraki S, et al. Fabrication and Characterization of Regenerated Silk/bioglass Composites for Bone Tissue Engineering. Modares J Med Sci Pathobiol 2012; 15(2): 47-60. (Persian) [Google Scholar]
3. Schmidmaier G, Capanna R, Wildemann B, et al. Bone morphogenetic proteins in critical-size bone defects: what are the options. Injury 2009; 40(3): S39-43. [PubMed] [Google Scholar]
4. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009; 25(6): 1539-60. [PubMed] [Google Scholar]
5. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends. Macromol Biosci 2004; 4(8): 743-65. [PubMed] [Google Scholar]
6. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 1991; 2(3): 187-208. [PubMed] [Google Scholar]
7. Hollinger JO, Einhorn TA, Doll B, et al. Bone tissue engineering. Boca Raton, Florida: CRC Press, 2004, 277-301. [Google Scholar]
8. Runyan CM, Taylor JA. Clinical applications of stem cells in craniofacial surgery. Facial Plast Surg 2010; 26(5): 385-95. [PubMed] [Google Scholar]
9. Yunoki S, Ikoma T, Monkawa A, et al. Control of pore structure and mechanical property in hydroxyapatite/collagen composite using unidirectional ice growth. Materials letters 2006; 60(8): 999-1002. [Google Scholar]
10. Mozafari M, Gholipourmalekabadi M, Chauhan NP, et al. Synthesis and characterization of nanocrystalline forsterite coated poly (l-lactide-co-β-malic acid) scaffolds for bone tissue engineering applications. Mater Sci Eng C Mater Biol Appl 2015; 50: 117-23. [PubMed] [Google Scholar]
11. Liao SS, Cui FZ, Zhu Y. Osteoblasts adherence and migration through three-dimensional porous mineralized collagen based composite: nHAC/PLA. J Bioactive Compatible Polymers 2004; 19(2): 117-30. [Google Scholar]
12. Zhang SM, Cui FZ, Liao SS, et al. Synthesis and biocompatibility of porous nano-hydroxyapatite/collagen/alginate composite. J Mater Sci Mater Med 2003; 14(7): 641-5. [PubMed] [Google Scholar]
13. Diba M, Kharaziha M, Fathi MH, et al. Preparation and characterization of polycaprolactone/forsterite nanocomposite porous scaffolds designed for bone tissue regeneration. Comp Sci Technol 2012; 72(6): 716-23. [Google Scholar]
14. Kim HW, Kim HE, Salih V. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials 2005; 26(25): 5221-30. [PubMed] [Google Scholar]
15. Wang J, Glimcher MJ. Temporal and Spatial Independence of Bone and Cartilage Induction by Demineralized Bone Powder in Cranial Defects and Subcutaneous Tissues of Rats. Connect Tissue Res 1996; 34: 116-70. [Google Scholar]
16. Ai J, Heidari-Keshel S, Azami M, et al. Repair of critical size rat calvarial defects using endometrial-derived stem cells embedded within gelatin/apatite nanocomposite scaffold. Stem Cell Disc 2013; 3(1): 36-43. [Google Scholar]
17. Joe AW, Gregory-Evans K. Mesenchymal stem cells and potential applications in treating ocular disease. Curr Eye Res 2010; 35(11): 941-52. [PubMed] [Google Scholar]
18. Bancroft JD, Stevens A.“Theory and Pracice Histological Techniques”. Scotland: Churchill Livingstone Publication Company, 1990, 133-5. [Google Scholar]
19. Karageorgiou V, kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26(27): 5474-91. [PubMed] [Google Scholar]
20. Takaoka K, Nakahara H, Yoshikawa H, et al. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthopaedics Related Res 1988; 234: 250-4. [PubMed] [Google Scholar]
21. Scott CK, Hightower JA. The matrix of endochondral bone differs from the matrix of intramembranous bone. Calcif Tissue Int 1991; 49(5): 349-54. [PubMed] [Google Scholar]
22. Yamashita K, Takagi T. Ultrastructural observation of calcification preceding new bone formation induced by demineralized bone matrix gelatin. Acta Anat (Basel) 1992; 143(4): 261-7. [PubMed] [Google Scholar]
23. Moghadam HG, Sándor GK, Holmes HH, et al. Histomorphometric evaluation of bone regeneration using allogeneic and alloplastic bone substitutes. J Oral maxillofac Surg 2004; 62(2): 202-13. [PubMed] [Google Scholar]
24. Kale AA, Di Cesare PE. Osteoinductive agents. Basic science and clinical applications. Am J Orthop (Belle Mead NJ) 1995; 24(10): 752-61. [PubMed]
25. Baghbani F, Moztarzadeh F, Nazari AG, et al. Biological response of biphasic hydroxyapatite/tricalcium phosphate scaffolds intended for low load-bearing orthopaedic applications. Adv Comp Lett 2012; 21(1): 16-24. [Google Scholar]
26. Gholipourmalekabadi M, Mozafari M, Gholipourmalekabadi M, et al. In vitro and in vivo evaluations of three‐dimensional hydroxyapatite/silk fibroin nanocomposite scaffolds. Biotechnol Appl Biochem 2015; 62(4): 441-50. [PubMed] [Google Scholar]
27. Kagami H, Agata H, Tojo A. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation. Int J of Bioch Cell Biol 2011; 43(3): 286-9. [PubMed] [Google Scholar]
28. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8(3): 301-16. [PubMed] [Google Scholar]
29. Aminian A, Solati-Hashjin M, Samadikuchaksaraei A, et al. Synthesis of silicon-substituted hydroxyapatite by a hydrothermal method with two different phosphorous sources. Ceram Int 2011; 37(4): 1219-29. [Google Scholar]
30. Azami M, Tavakol Sh, Samadikuchaksaraei A, et al. A porous hydroxyapatite/gelatin nanocomposite scaffold for bone tissue repair: in vitro and in vivo evaluation. J Biomater Sci Polym Edition 2012; 23(18): 2353-68. [PubMed] [Google Scholar]
31. Zare M, Baghaban Eslaminejad MR, Hosseini A. Study of mesanchymal stem cells derived from human umbilical cord vein wall and determining the Process of differentiation to cartilage and bone. Iran South Med J 2015; 17(6): 1135-42. (Persian) [Google Scholar]
32. Nabipour I. The future of 3D printing technology in biomedicine. Iran South Med J 2015; 18 (3): 680-8. (Persian) [Google Scholar]
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Behruzi M, Ghasemi Hamidabadi H, Gholipour Malekabadi M, Rezaei N, Nazm Bojnordi M, Malekzadeh Shafaroudi M. Using Hydroxyapatite-Gelatin Scaffold Seeded with Bone Marrow Stromal Cells as a Bone Graft in Animal Model. Iran South Med J. 2016; 19 (5) :773-786
URL: http://ismj.bpums.ac.ir/article-1-826-en.html

Volume 19, Issue 5 (Iranian South Medical Journal 2016) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.07 seconds with 31 queries by YEKTAWEB 4140